Kezar Life Sciences : Failure to Satisfy Listing Rule Form 8

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.


As previously disclosed on a Current Report on Form 8-K filed by...

Related Keywords

, Nasdaq Stock Market , Nasdaq Listing Qualifications Panel , Kezar Life Sciences Inc , Company On , Nasdaq , Continued Listing Rule , Current Report , Kezar Life Sciences , Listing Qualifications Staff , Nasdaq Listing Rule , November May , Nasdaq Capital Market , Nasdaq Global Select Market , Second Compliance Date , Nasdaq Listing Qualifications ,